Mosquito allergy: Immunological aspects and clinical management
- PMID: 38039596
- DOI: 10.1016/j.molimm.2023.11.009
Mosquito allergy: Immunological aspects and clinical management
Abstract
Mosquito allergy has been conceived as the cutaneous reactions that appears during and after mosquito biting process; a perception that is supported by several scientific research. Additional data have led to conceive that other manifestations of allergic responses may occur as a cause of the exposure to somatic mosquito allergens. Two main phenotypes of mosquito allergy are identifiable: the cutaneous allergic reactions, induced by salivary allergens, and other manifestations of the allergic responses such as asthma and allergic rhino conjunctivitis that are caused by somatic allergens. The cutaneous reactions have kept the focus of attention of the scientific community. It appears as skin lesions that resembles the phenotype of papular urticaria with a defined natural history of the disease. Although these two phenotypes of mosquito allergy seem to be well differentiated in terms of the allergens that are involved and the routes of exposures, other factors such as geographical distribution, may participate. Mosquitoes have adapted to the host immune response against bites, producing immunomodulatory molecules that counteract such defensive response. The role that the immunomodulatory molecules have on the allergic immune response has not been studied yet and it is still not known if affects all mosquito allergy phenotypes. Only a few studies of allergen specific immunotherapy for cutaneous allergic reactions induced by mosquito bites have been done, and none for respiratory allergic responses. The clinical practice focuses on symptom management and avoiding mosquito bites as much as possible. Avoiding mosquitoes, using different well described methods, is still the best option to limit contact with these insects. The lack of knowledge of mosquito allergy have raised several questions that affects the clinical management of this allergic disease, from its diagnosis, prevention and immunotherapy.
Keywords: Aedes aegypti; Allergens; Cross-reactivity; Mosquito allergy; Mosquito repelents.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of Interest JFC is an employe at the company Inmunotek, S.L. EFC was an employe at the company Inmunotek. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Advances in mosquito allergy.Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):350-4. doi: 10.1097/ACI.0b013e328259c313. Curr Opin Allergy Clin Immunol. 2007. PMID: 17620829 Review.
-
Immunological aspects of the immune response induced by mosquito allergens.Int Arch Allergy Immunol. 2014;165(4):271-82. doi: 10.1159/000371349. Epub 2015 Feb 6. Int Arch Allergy Immunol. 2014. PMID: 25661054 Review.
-
Mosquito allergy: immune mechanisms and recombinant salivary allergens.Int Arch Allergy Immunol. 2004 Feb;133(2):198-209. doi: 10.1159/000076787. Epub 2004 Feb 11. Int Arch Allergy Immunol. 2004. PMID: 14963366 Review.
-
Efficacy and safety of specific immunotherapy to mosquito bites.Eur Ann Allergy Clin Immunol. 2004 Apr;36(4):131-8. Eur Ann Allergy Clin Immunol. 2004. PMID: 15180354
-
[Prevalence of reactions secundary to mosquito bites Aedes aegypti at en el Regional Center of Allergy and Clinical Immunology, University Hospital, de Monterrey, Nuevo Leon].Rev Alerg Mex. 2010 Mar-Apr;57(2):37-43. Rev Alerg Mex. 2010. PMID: 20857628 Spanish.
Cited by
-
Fusarium begoniae metabolites: a promising larvicidal, pupicidal potential, histopathological alterations and detoxifications enzyme profiles of medically important mosquito vector Aedes aegypti, Culex quinquefasciatus and Anopheles stephensi.3 Biotech. 2024 Oct;14(10):226. doi: 10.1007/s13205-024-04061-z. Epub 2024 Sep 10. 3 Biotech. 2024. PMID: 39263325
-
Preliminary Bioactivity Assessment of Myrothecium Species (Stachybotryaceae) Crude Extracts against Aedes aegypti (Diptera: Culicidae): A First Approach from This Phytopathogenic Fungi.J Fungi (Basel). 2024 Jul 2;10(7):466. doi: 10.3390/jof10070466. J Fungi (Basel). 2024. PMID: 39057351 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical